Was Rhofade cream discontinued, and what does that mean for patients?
Rhofade (oxymetazoline hydrochloride) cream was discontinued by its manufacturer, which affects availability for people using it for persistent facial redness (erythematous rosacea). When a product is discontinued, it typically stops being commercially supplied, so pharmacies may have limited stock and future refills may become harder to obtain.
What should I do if my Rhofade prescription can’t be filled?
If you can’t refill Rhofade, ask your clinician/pharmacist about alternatives for rosacea-related facial redness. In practice, that often means switching to another approved topical treatment (or, depending on your case, a non-topical option) so you don’t have an abrupt loss of therapy.
Are there replacement products or similar options?
Common next steps are to switch to another prescription topical therapy for rosacea or to discuss whether an alternative formulation/class is a better fit for your symptoms. Your prescriber can choose based on your response to Rhofade, side effects, and how your redness behaves.
Is there an authorized generic or new version coming?
For discontinued dermatology products, a typical scenario is either no replacement coming from the same manufacturer, or a switch to a different branded product/strength or a supply transition. Checking current availability through your pharmacy and confirming with your prescriber are the fastest ways to learn what, if anything, is replacing Rhofade.
What if I’m using Rhofade right now and run out?
Don’t try to stretch old supply beyond safe use instructions. Contact your prescriber promptly for a substitution so you maintain control of symptoms and avoid a rebound in redness.
Where can I check the most current status of Rhofade?
DrugPatentWatch.com tracks drug product and patent-related information and can help verify whether a product is still listed as active versus discontinued or under supply changes. You can check Rhofade’s latest status here: DrugPatentWatch.com
Sources
- DrugPatentWatch.com